GO:0140513 | nuclear protein-containing complex | 25.42% (15/59) | 2.74 | 0.0 | 6e-06 |
GO:0032991 | protein-containing complex | 40.68% (24/59) | 1.72 | 0.0 | 2.3e-05 |
GO:0060255 | regulation of macromolecule metabolic process | 45.76% (27/59) | 1.53 | 0.0 | 2.4e-05 |
GO:0016070 | RNA metabolic process | 28.81% (17/59) | 2.27 | 0.0 | 3e-05 |
GO:0051171 | regulation of nitrogen compound metabolic process | 42.37% (25/59) | 1.54 | 0.0 | 7.1e-05 |
GO:0032806 | carboxy-terminal domain protein kinase complex | 6.78% (4/59) | 5.98 | 1e-06 | 0.000139 |
GO:0080090 | regulation of primary metabolic process | 42.37% (25/59) | 1.45 | 1e-06 | 0.000178 |
GO:0005654 | nucleoplasm | 22.03% (13/59) | 2.27 | 2e-06 | 0.000424 |
GO:0090304 | nucleic acid metabolic process | 28.81% (17/59) | 1.8 | 3e-06 | 0.000579 |
GO:0019222 | regulation of metabolic process | 45.76% (27/59) | 1.25 | 3e-06 | 0.000603 |
GO:0010468 | regulation of gene expression | 35.59% (21/59) | 1.47 | 7e-06 | 0.001013 |
GO:0046831 | regulation of RNA export from nucleus | 5.08% (3/59) | 6.26 | 8e-06 | 0.001062 |
GO:0005681 | spliceosomal complex | 10.17% (6/59) | 3.67 | 8e-06 | 0.0011 |
GO:0032239 | regulation of nucleobase-containing compound transport | 5.08% (3/59) | 6.2 | 9e-06 | 0.001108 |
GO:0000398 | mRNA splicing, via spliceosome | 8.47% (5/59) | 4.1 | 1.1e-05 | 0.001248 |
GO:0006139 | nucleobase-containing compound metabolic process | 30.51% (18/59) | 1.6 | 1.3e-05 | 0.001314 |
GO:0006397 | mRNA processing | 11.86% (7/59) | 3.12 | 1.5e-05 | 0.001508 |
GO:0031323 | regulation of cellular metabolic process | 38.98% (23/59) | 1.26 | 2.5e-05 | 0.001748 |
GO:0010556 | regulation of macromolecule biosynthetic process | 30.51% (18/59) | 1.52 | 2.7e-05 | 0.001768 |
GO:0070827 | obsolete chromatin maintenance | 3.39% (2/59) | 8.05 | 2.2e-05 | 0.001772 |
GO:0031441 | negative regulation of mRNA 3'-end processing | 3.39% (2/59) | 8.05 | 2.2e-05 | 0.001772 |
GO:1900364 | negative regulation of mRNA polyadenylation | 3.39% (2/59) | 8.05 | 2.2e-05 | 0.001772 |
GO:0032784 | regulation of DNA-templated transcription elongation | 6.78% (4/59) | 4.58 | 2.5e-05 | 0.0018 |
GO:0008380 | RNA splicing | 10.17% (6/59) | 3.44 | 1.9e-05 | 0.001803 |
GO:0004693 | cyclin-dependent protein serine/threonine kinase activity | 5.08% (3/59) | 5.56 | 3.6e-05 | 0.001815 |
GO:0097472 | cyclin-dependent protein kinase activity | 5.08% (3/59) | 5.56 | 3.6e-05 | 0.001815 |
GO:0050684 | regulation of mRNA processing | 8.47% (5/59) | 3.82 | 2.8e-05 | 0.001816 |
GO:0051252 | regulation of RNA metabolic process | 28.81% (17/59) | 1.54 | 3.9e-05 | 0.00184 |
GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex | 5.08% (3/59) | 5.75 | 2.4e-05 | 0.001853 |
GO:0008353 | RNA polymerase II CTD heptapeptide repeat kinase activity | 5.08% (3/59) | 5.53 | 3.9e-05 | 0.001892 |
GO:1903311 | regulation of mRNA metabolic process | 10.17% (6/59) | 3.28 | 3.6e-05 | 0.001918 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 8.47% (5/59) | 3.79 | 3.1e-05 | 0.001934 |
GO:0000375 | RNA splicing, via transesterification reactions | 8.47% (5/59) | 3.76 | 3.5e-05 | 0.001959 |
GO:0065003 | protein-containing complex assembly | 16.95% (10/59) | 2.28 | 3.4e-05 | 0.002004 |
GO:0005829 | cytosol | 35.59% (21/59) | 1.32 | 3.5e-05 | 0.002026 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 5.08% (3/59) | 5.43 | 4.7e-05 | 0.002132 |
GO:1901970 | positive regulation of mitotic sister chromatid separation | 5.08% (3/59) | 5.43 | 4.7e-05 | 0.002132 |
GO:0046822 | regulation of nucleocytoplasmic transport | 6.78% (4/59) | 4.33 | 4.9e-05 | 0.002147 |
GO:1902554 | serine/threonine protein kinase complex | 6.78% (4/59) | 4.28 | 5.5e-05 | 0.00235 |
GO:0007088 | regulation of mitotic nuclear division | 6.78% (4/59) | 4.23 | 6.3e-05 | 0.002636 |
GO:0033043 | regulation of organelle organization | 13.56% (8/59) | 2.51 | 7.5e-05 | 0.003047 |
GO:0048522 | positive regulation of cellular process | 33.9% (20/59) | 1.29 | 7.7e-05 | 0.003055 |
GO:0051246 | regulation of protein metabolic process | 20.34% (12/59) | 1.88 | 8e-05 | 0.003107 |
GO:0140098 | catalytic activity, acting on RNA | 11.86% (7/59) | 2.73 | 8.7e-05 | 0.003158 |
GO:0003723 | RNA binding | 22.03% (13/59) | 1.76 | 8.6e-05 | 0.003177 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 8.47% (5/59) | 3.46 | 9.2e-05 | 0.003188 |
GO:1902911 | protein kinase complex | 6.78% (4/59) | 4.1 | 9.1e-05 | 0.003238 |
GO:0045840 | positive regulation of mitotic nuclear division | 5.08% (3/59) | 5.15 | 8.6e-05 | 0.003239 |
GO:0016071 | mRNA metabolic process | 13.56% (8/59) | 2.44 | 0.000108 | 0.00359 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 28.81% (17/59) | 1.42 | 0.000111 | 0.003618 |
GO:1902494 | catalytic complex | 18.64% (11/59) | 1.94 | 0.000113 | 0.003624 |
GO:0043933 | protein-containing complex organization | 16.95% (10/59) | 2.08 | 0.000107 | 0.003648 |
GO:1902101 | positive regulation of metaphase/anaphase transition of cell cycle | 5.08% (3/59) | 4.98 | 0.000122 | 0.003752 |
GO:1905820 | positive regulation of chromosome separation | 5.08% (3/59) | 4.98 | 0.000122 | 0.003752 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 13.56% (8/59) | 2.39 | 0.000137 | 0.004154 |
GO:0006396 | RNA processing | 16.95% (10/59) | 1.97 | 0.000202 | 0.005087 |
GO:0040021 | hermaphrodite germ-line sex determination | 3.39% (2/59) | 6.56 | 0.000201 | 0.005163 |
GO:0040022 | feminization of hermaphroditic germ-line | 3.39% (2/59) | 6.56 | 0.000201 | 0.005163 |
GO:0006355 | regulation of DNA-templated transcription | 25.42% (15/59) | 1.5 | 0.000174 | 0.00517 |
GO:2001141 | regulation of RNA biosynthetic process | 25.42% (15/59) | 1.49 | 0.00018 | 0.005183 |
GO:0048518 | positive regulation of biological process | 37.29% (22/59) | 1.11 | 0.000197 | 0.005201 |
GO:0050657 | nucleic acid transport | 6.78% (4/59) | 3.82 | 0.000188 | 0.005219 |
GO:0050658 | RNA transport | 6.78% (4/59) | 3.82 | 0.000188 | 0.005219 |
GO:0051236 | establishment of RNA localization | 6.78% (4/59) | 3.82 | 0.000192 | 0.005239 |
GO:1903506 | regulation of nucleic acid-templated transcription | 25.42% (15/59) | 1.49 | 0.000179 | 0.005241 |
GO:0008134 | transcription factor binding | 10.17% (6/59) | 2.83 | 0.000196 | 0.005254 |
GO:0001099 | basal RNA polymerase II transcription machinery binding | 5.08% (3/59) | 4.69 | 0.000221 | 0.005488 |
GO:0051726 | regulation of cell cycle | 13.56% (8/59) | 2.27 | 0.000238 | 0.005594 |
GO:0001098 | basal transcription machinery binding | 5.08% (3/59) | 4.65 | 0.000238 | 0.005666 |
GO:0070063 | RNA polymerase binding | 5.08% (3/59) | 4.65 | 0.000238 | 0.005666 |
GO:0010793 | regulation of mRNA export from nucleus | 3.39% (2/59) | 6.46 | 0.000232 | 0.005689 |
GO:0006357 | regulation of transcription by RNA polymerase II | 15.25% (9/59) | 2.08 | 0.000248 | 0.005741 |
GO:0051783 | regulation of nuclear division | 6.78% (4/59) | 3.71 | 0.000252 | 0.005757 |
GO:0051785 | positive regulation of nuclear division | 5.08% (3/59) | 4.62 | 0.000256 | 0.00577 |
GO:0060303 | obsolete regulation of nucleosome density | 3.39% (2/59) | 6.37 | 0.000265 | 0.00589 |
GO:0009889 | regulation of biosynthetic process | 30.51% (18/59) | 1.25 | 0.000284 | 0.006235 |
GO:0002944 | cyclin K-CDK12 complex | 3.39% (2/59) | 6.28 | 0.0003 | 0.006252 |
GO:0002945 | cyclin K-CDK13 complex | 3.39% (2/59) | 6.28 | 0.0003 | 0.006252 |
GO:0000439 | transcription factor TFIIH core complex | 3.39% (2/59) | 6.28 | 0.0003 | 0.006252 |
GO:0010604 | positive regulation of macromolecule metabolic process | 23.73% (14/59) | 1.5 | 0.000291 | 0.006304 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 5.08% (3/59) | 4.48 | 0.000338 | 0.006872 |
GO:0090239 | regulation of histone H4 acetylation | 3.39% (2/59) | 6.2 | 0.000337 | 0.00694 |
GO:0034243 | regulation of transcription elongation by RNA polymerase II | 5.08% (3/59) | 4.46 | 0.00035 | 0.007016 |
GO:0009893 | positive regulation of metabolic process | 25.42% (15/59) | 1.4 | 0.000367 | 0.007288 |
GO:0050794 | regulation of cellular process | 50.85% (30/59) | 0.8 | 0.000379 | 0.00743 |
GO:0010965 | regulation of mitotic sister chromatid separation | 5.08% (3/59) | 4.39 | 0.00041 | 0.007844 |
GO:0046483 | heterocycle metabolic process | 30.51% (18/59) | 1.21 | 0.000407 | 0.007875 |
GO:1900363 | regulation of mRNA polyadenylation | 3.39% (2/59) | 6.05 | 0.000418 | 0.007917 |
GO:2000197 | regulation of ribonucleoprotein complex localization | 3.39% (2/59) | 5.98 | 0.000462 | 0.008454 |
GO:0045943 | positive regulation of transcription by RNA polymerase I | 3.39% (2/59) | 5.98 | 0.000462 | 0.008454 |
GO:0010628 | positive regulation of gene expression | 11.86% (7/59) | 2.33 | 0.00046 | 0.008615 |
GO:0006913 | nucleocytoplasmic transport | 6.78% (4/59) | 3.46 | 0.000492 | 0.008903 |
GO:0018992 | germ-line sex determination | 3.39% (2/59) | 5.91 | 0.000507 | 0.008993 |
GO:0051169 | nuclear transport | 6.78% (4/59) | 3.45 | 0.000507 | 0.009085 |
GO:0000307 | cyclin-dependent protein kinase holoenzyme complex | 5.08% (3/59) | 4.24 | 0.000549 | 0.009525 |
GO:1903312 | negative regulation of mRNA metabolic process | 5.08% (3/59) | 4.24 | 0.000549 | 0.009525 |
GO:0051649 | establishment of localization in cell | 15.25% (9/59) | 1.91 | 0.000582 | 0.009991 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 5.08% (3/59) | 4.19 | 0.000612 | 0.009997 |
GO:0060341 | regulation of cellular localization | 10.17% (6/59) | 2.52 | 0.000607 | 0.01002 |
GO:0034641 | cellular nitrogen compound metabolic process | 30.51% (18/59) | 1.16 | 0.000623 | 0.010073 |
GO:0035578 | azurophil granule lumen | 3.39% (2/59) | 5.79 | 0.000605 | 0.010081 |
GO:0051641 | cellular localization | 18.64% (11/59) | 1.66 | 0.000601 | 0.010119 |
GO:0031326 | regulation of cellular biosynthetic process | 28.81% (17/59) | 1.22 | 0.000596 | 0.01013 |
GO:0008024 | cyclin/CDK positive transcription elongation factor complex | 3.39% (2/59) | 5.73 | 0.000657 | 0.010526 |
GO:0005575 | cellular_component | 81.36% (48/59) | 0.41 | 0.000667 | 0.010578 |
GO:0033045 | regulation of sister chromatid segregation | 5.08% (3/59) | 4.12 | 0.000697 | 0.010857 |
GO:0050790 | regulation of catalytic activity | 13.56% (8/59) | 2.04 | 0.000696 | 0.010939 |
GO:1905818 | regulation of chromosome separation | 5.08% (3/59) | 4.09 | 0.000752 | 0.011493 |
GO:0006725 | cellular aromatic compound metabolic process | 32.2% (19/59) | 1.09 | 0.000751 | 0.01159 |
GO:0032386 | regulation of intracellular transport | 6.78% (4/59) | 3.28 | 0.000773 | 0.011598 |
GO:0034515 | proteasome storage granule | 3.39% (2/59) | 5.62 | 0.000767 | 0.011621 |
GO:0008540 | proteasome regulatory particle, base subcomplex | 3.39% (2/59) | 5.56 | 0.000826 | 0.01228 |
GO:0051130 | positive regulation of cellular component organization | 10.17% (6/59) | 2.43 | 0.000843 | 0.012429 |
GO:0050789 | regulation of biological process | 54.24% (32/59) | 0.69 | 0.000854 | 0.012483 |
GO:2001253 | regulation of histone H3-K36 trimethylation | 3.39% (2/59) | 5.51 | 0.000886 | 0.012833 |
GO:0046907 | intracellular transport | 13.56% (8/59) | 1.97 | 0.000942 | 0.013536 |
GO:0033044 | regulation of chromosome organization | 6.78% (4/59) | 3.15 | 0.001084 | 0.014919 |
GO:2000737 | negative regulation of stem cell differentiation | 3.39% (2/59) | 5.37 | 0.001079 | 0.01498 |
GO:0016973 | poly(A)+ mRNA export from nucleus | 3.39% (2/59) | 5.37 | 0.001079 | 0.01498 |
GO:0031440 | regulation of mRNA 3'-end processing | 3.39% (2/59) | 5.37 | 0.001079 | 0.01498 |
GO:0050686 | negative regulation of mRNA processing | 3.39% (2/59) | 5.37 | 0.001079 | 0.01498 |
GO:1901992 | positive regulation of mitotic cell cycle phase transition | 5.08% (3/59) | 3.89 | 0.001113 | 0.015198 |
GO:0098772 | molecular function regulator activity | 11.86% (7/59) | 2.11 | 0.001146 | 0.015524 |
GO:0051983 | regulation of chromosome segregation | 5.08% (3/59) | 3.87 | 0.001161 | 0.015604 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 3.39% (2/59) | 5.28 | 0.001218 | 0.016106 |
GO:0006367 | transcription initiation at RNA polymerase II promoter | 3.39% (2/59) | 5.28 | 0.001218 | 0.016106 |
GO:0008298 | intracellular mRNA localization | 3.39% (2/59) | 5.24 | 0.001291 | 0.016798 |
GO:0000414 | regulation of histone H3-K36 methylation | 3.39% (2/59) | 5.24 | 0.001291 | 0.016798 |
GO:0071013 | catalytic step 2 spliceosome | 5.08% (3/59) | 3.79 | 0.001369 | 0.01754 |
GO:0071230 | cellular response to amino acid stimulus | 3.39% (2/59) | 5.2 | 0.001365 | 0.017632 |
GO:0015931 | nucleobase-containing compound transport | 6.78% (4/59) | 3.05 | 0.001408 | 0.017903 |
GO:1990904 | ribonucleoprotein complex | 11.86% (7/59) | 2.06 | 0.001421 | 0.017934 |
GO:0090284 | obsolete positive regulation of protein glycosylation in Golgi | 1.69% (1/59) | 9.37 | 0.001509 | 0.017962 |
GO:0048867 | stem cell fate determination | 1.69% (1/59) | 9.37 | 0.001509 | 0.017962 |
GO:0001096 | TFIIF-class transcription factor complex binding | 1.69% (1/59) | 9.37 | 0.001509 | 0.017962 |
GO:0005674 | transcription factor TFIIF complex | 1.69% (1/59) | 9.37 | 0.001509 | 0.017962 |
GO:0061632 | RNA lariat debranching enzyme activator activity | 1.69% (1/59) | 9.37 | 0.001509 | 0.017962 |
GO:0006356 | regulation of transcription by RNA polymerase I | 3.39% (2/59) | 5.16 | 0.001442 | 0.018061 |
GO:0090575 | RNA polymerase II transcription regulator complex | 5.08% (3/59) | 3.73 | 0.001538 | 0.018177 |
GO:0051028 | mRNA transport | 5.08% (3/59) | 3.74 | 0.001509 | 0.018625 |
GO:0051168 | nuclear export | 5.08% (3/59) | 3.74 | 0.001509 | 0.018625 |
GO:0005515 | protein binding | 57.63% (34/59) | 0.61 | 0.001612 | 0.018914 |
GO:0005684 | U2-type spliceosomal complex | 5.08% (3/59) | 3.68 | 0.001689 | 0.019412 |
GO:0007530 | sex determination | 3.39% (2/59) | 5.05 | 0.001684 | 0.01948 |
GO:0043248 | proteasome assembly | 3.39% (2/59) | 5.05 | 0.001684 | 0.01948 |
GO:0008022 | protein C-terminus binding | 5.08% (3/59) | 3.67 | 0.001721 | 0.019636 |
GO:0032481 | positive regulation of type I interferon production | 3.39% (2/59) | 5.01 | 0.001768 | 0.020042 |
GO:0007030 | Golgi organization | 5.08% (3/59) | 3.65 | 0.001784 | 0.020087 |
GO:0019901 | protein kinase binding | 8.47% (5/59) | 2.51 | 0.001844 | 0.020615 |
GO:1901989 | positive regulation of cell cycle phase transition | 5.08% (3/59) | 3.63 | 0.001883 | 0.02091 |
GO:0031152 | aggregation involved in sorocarp development | 3.39% (2/59) | 4.95 | 0.001944 | 0.021444 |
GO:0045931 | positive regulation of mitotic cell cycle | 5.08% (3/59) | 3.56 | 0.002161 | 0.023685 |
GO:0030234 | enzyme regulator activity | 10.17% (6/59) | 2.16 | 0.002201 | 0.023962 |
GO:1901360 | organic cyclic compound metabolic process | 32.2% (19/59) | 0.96 | 0.002256 | 0.024402 |
GO:0000993 | RNA polymerase II complex binding | 3.39% (2/59) | 4.82 | 0.002318 | 0.024912 |
GO:0071014 | post-mRNA release spliceosomal complex | 3.39% (2/59) | 4.79 | 0.002416 | 0.025477 |
GO:0048193 | Golgi vesicle transport | 6.78% (4/59) | 2.84 | 0.002386 | 0.025478 |
GO:0032774 | RNA biosynthetic process | 6.78% (4/59) | 2.84 | 0.002409 | 0.025564 |
GO:0010638 | positive regulation of organelle organization | 6.78% (4/59) | 2.8 | 0.002626 | 0.027343 |
GO:0045787 | positive regulation of cell cycle | 6.78% (4/59) | 2.8 | 0.002651 | 0.027431 |
GO:0043175 | RNA polymerase core enzyme binding | 3.39% (2/59) | 4.73 | 0.002619 | 0.02744 |
GO:0006403 | RNA localization | 3.39% (2/59) | 4.7 | 0.002723 | 0.028004 |
GO:0032479 | regulation of type I interferon production | 3.39% (2/59) | 4.62 | 0.003047 | 0.029178 |
GO:0030120 | vesicle coat | 3.39% (2/59) | 4.62 | 0.003047 | 0.029178 |
GO:0070679 | inositol 1,4,5 trisphosphate binding | 1.69% (1/59) | 8.37 | 0.003017 | 0.029219 |
GO:0005796 | Golgi lumen | 1.69% (1/59) | 8.37 | 0.003017 | 0.029219 |
GO:0021768 | nucleus accumbens development | 1.69% (1/59) | 8.37 | 0.003017 | 0.029219 |
GO:0060166 | olfactory pit development | 1.69% (1/59) | 8.37 | 0.003017 | 0.029219 |
GO:0070384 | Harderian gland development | 1.69% (1/59) | 8.37 | 0.003017 | 0.029219 |
GO:0004825 | methionine-tRNA ligase activity | 1.69% (1/59) | 8.37 | 0.003017 | 0.029219 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 1.69% (1/59) | 8.37 | 0.003017 | 0.029219 |
GO:0006399 | tRNA metabolic process | 6.78% (4/59) | 2.74 | 0.0031 | 0.029508 |
GO:0031325 | positive regulation of cellular metabolic process | 20.34% (12/59) | 1.3 | 0.002898 | 0.029615 |
GO:0043170 | macromolecule metabolic process | 38.98% (23/59) | 0.8 | 0.002952 | 0.029986 |
GO:0110165 | cellular anatomical entity | 77.97% (46/59) | 0.37 | 0.002995 | 0.030239 |
GO:0065009 | regulation of molecular function | 15.25% (9/59) | 1.56 | 0.003203 | 0.03032 |
GO:0008023 | transcription elongation factor complex | 3.39% (2/59) | 4.54 | 0.003389 | 0.031898 |
GO:0008104 | protein localization | 13.56% (8/59) | 1.67 | 0.003459 | 0.032375 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 3.39% (2/59) | 4.51 | 0.003507 | 0.032637 |
GO:0030425 | dendrite | 5.08% (3/59) | 3.28 | 0.003673 | 0.033996 |
GO:0022607 | cellular component assembly | 16.95% (10/59) | 1.42 | 0.003719 | 0.034236 |
GO:0005776 | autophagosome | 3.39% (2/59) | 4.42 | 0.003996 | 0.036579 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 1.69% (1/59) | 7.79 | 0.004522 | 0.03903 |
GO:0048857 | neural nucleus development | 1.69% (1/59) | 7.79 | 0.004522 | 0.03903 |
GO:0032051 | clathrin light chain binding | 1.69% (1/59) | 7.79 | 0.004522 | 0.03903 |
GO:0035159 | regulation of tube length, open tracheal system | 1.69% (1/59) | 7.79 | 0.004522 | 0.03903 |
GO:1990763 | arrestin family protein binding | 1.69% (1/59) | 7.79 | 0.004522 | 0.03903 |
GO:0004631 | phosphomevalonate kinase activity | 1.69% (1/59) | 7.79 | 0.004522 | 0.03903 |
GO:0006431 | methionyl-tRNA aminoacylation | 1.69% (1/59) | 7.79 | 0.004522 | 0.03903 |
GO:0043630 | ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process | 1.69% (1/59) | 7.79 | 0.004522 | 0.03903 |
GO:0019899 | enzyme binding | 15.25% (9/59) | 1.48 | 0.004618 | 0.039658 |
GO:0005488 | binding | 67.8% (40/59) | 0.44 | 0.004421 | 0.040249 |
GO:0032559 | adenyl ribonucleotide binding | 15.25% (9/59) | 1.47 | 0.004789 | 0.040292 |
GO:0065007 | biological regulation | 54.24% (32/59) | 0.56 | 0.004464 | 0.040416 |
GO:0004812 | aminoacyl-tRNA ligase activity | 3.39% (2/59) | 4.28 | 0.004786 | 0.040474 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.39% (2/59) | 4.28 | 0.004786 | 0.040474 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 3.39% (2/59) | 4.28 | 0.004786 | 0.040474 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 15.25% (9/59) | 1.46 | 0.00489 | 0.040535 |
GO:0030554 | adenyl nucleotide binding | 15.25% (9/59) | 1.46 | 0.004949 | 0.040619 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 3.39% (2/59) | 4.33 | 0.004515 | 0.040662 |
GO:0043228 | non-membrane-bounded organelle | 20.34% (12/59) | 1.2 | 0.004884 | 0.040685 |
GO:0043232 | intracellular non-membrane-bounded organelle | 20.34% (12/59) | 1.2 | 0.004884 | 0.040685 |
GO:0045727 | positive regulation of translation | 5.08% (3/59) | 3.13 | 0.004946 | 0.040792 |
GO:2000736 | regulation of stem cell differentiation | 3.39% (2/59) | 4.24 | 0.005064 | 0.041356 |
GO:0010564 | regulation of cell cycle process | 8.47% (5/59) | 2.15 | 0.005351 | 0.042449 |
GO:0003725 | double-stranded RNA binding | 3.39% (2/59) | 4.2 | 0.005349 | 0.042641 |
GO:0043038 | amino acid activation | 3.39% (2/59) | 4.2 | 0.005349 | 0.042641 |
GO:0043039 | tRNA aminoacylation | 3.39% (2/59) | 4.2 | 0.005349 | 0.042641 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 18.64% (11/59) | 1.26 | 0.005323 | 0.043045 |
GO:0034660 | ncRNA metabolic process | 10.17% (6/59) | 1.9 | 0.005298 | 0.043053 |
GO:0034237 | protein kinase A regulatory subunit binding | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:0030506 | ankyrin binding | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:0071439 | clathrin complex | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:0017102 | methionyl glutamyl tRNA synthetase complex | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:0055122 | response to very low light intensity stimulus | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:0016077 | sno(s)RNA catabolic process | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:0071076 | RNA 3' uridylation | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:0044828 | negative regulation by host of viral genome replication | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:2001163 | regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:2001165 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues | 1.69% (1/59) | 7.37 | 0.006024 | 0.044019 |
GO:0005775 | vacuolar lumen | 3.39% (2/59) | 4.11 | 0.006094 | 0.044336 |
GO:0000049 | tRNA binding | 3.39% (2/59) | 4.16 | 0.005642 | 0.044547 |
GO:0043484 | regulation of RNA splicing | 5.08% (3/59) | 3.01 | 0.006175 | 0.044731 |
GO:0031983 | vesicle lumen | 3.39% (2/59) | 4.14 | 0.005791 | 0.044873 |
GO:0034774 | secretory granule lumen | 3.39% (2/59) | 4.14 | 0.005791 | 0.044873 |
GO:0060205 | cytoplasmic vesicle lumen | 3.39% (2/59) | 4.14 | 0.005791 | 0.044873 |
GO:0006406 | mRNA export from nucleus | 3.39% (2/59) | 4.09 | 0.006249 | 0.045065 |
GO:1990234 | transferase complex | 10.17% (6/59) | 1.88 | 0.005765 | 0.045302 |
GO:0030117 | membrane coat | 3.39% (2/59) | 4.07 | 0.006405 | 0.045992 |
GO:0031399 | regulation of protein modification process | 10.17% (6/59) | 1.84 | 0.006563 | 0.046725 |
GO:0070727 | cellular macromolecule localization | 13.56% (8/59) | 1.51 | 0.006555 | 0.046869 |
GO:0043167 | ion binding | 32.2% (19/59) | 0.83 | 0.006617 | 0.046908 |
GO:0051128 | regulation of cellular component organization | 15.25% (9/59) | 1.39 | 0.00665 | 0.046941 |
GO:0030198 | extracellular matrix organization | 3.39% (2/59) | 4.03 | 0.006722 | 0.047055 |
GO:0097367 | carbohydrate derivative binding | 16.95% (10/59) | 1.3 | 0.006704 | 0.047123 |
GO:0043062 | extracellular structure organization | 3.39% (2/59) | 4.01 | 0.006884 | 0.047784 |
GO:0071005 | U2-type precatalytic spliceosome | 3.39% (2/59) | 4.01 | 0.006884 | 0.047784 |
GO:0010639 | negative regulation of organelle organization | 5.08% (3/59) | 2.91 | 0.007572 | 0.047967 |
GO:0090307 | mitotic spindle assembly | 3.39% (2/59) | 3.95 | 0.007547 | 0.047988 |
GO:0090303 | positive regulation of wound healing | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0061026 | cardiac muscle tissue regeneration | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0090594 | inflammatory response to wounding | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0035115 | embryonic forelimb morphogenesis | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0035799 | ureter maturation | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0048384 | retinoic acid receptor signaling pathway | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0048799 | animal organ maturation | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0090242 | retinoic acid receptor signaling pathway involved in somitogenesis | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0000301 | retrograde transport, vesicle recycling within Golgi | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:1900125 | regulation of hyaluronan biosynthetic process | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0036120 | cellular response to platelet-derived growth factor stimulus | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0060717 | chorion development | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:1903867 | extraembryonic membrane development | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0071232 | cellular response to histidine | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0072559 | NLRP3 inflammasome complex | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0009328 | phenylalanine-tRNA ligase complex | 1.69% (1/59) | 7.05 | 0.007525 | 0.048031 |
GO:0007346 | regulation of mitotic cell cycle | 6.78% (4/59) | 2.4 | 0.006962 | 0.048128 |
GO:0042327 | positive regulation of phosphorylation | 5.08% (3/59) | 2.9 | 0.007651 | 0.04828 |
GO:0034250 | positive regulation of cellular amide metabolic process | 5.08% (3/59) | 2.95 | 0.007038 | 0.04845 |
GO:0035196 | miRNA processing | 3.39% (2/59) | 3.93 | 0.007717 | 0.048514 |